Compared to normal tissues, S1PR1 mRNA expression was significantly decreased in primary tumors and tumor stages (stage 1, stage 2, stage 3, and stage 4) of BRCA, LUAD, and LUSC (Fig. 3c–e). This evidence concerns the gene S1PR1 and neoplasm.